19305457 30780873 20540734 17973939 32875953 15808130 20418229 31486712 30289349 17209221 22863386 28830021 18971594 21854403 19594818 20625722 17991805 17524031 17129985 22435785 15762182 18405877 17848839 23563523 28537653 19402203 23258272 1914927 - Search Results

Year	Number of Results
2005	2
2006	1
2007	5
2008	5
2009	3
2010	3
2011	1
2012	3
2013	2
2017	2
2018	1
2019	1
2020	1
2021	1
2022	0

1

Overshooting the mark: subclinical hyperthyroidism secondary to excess thyroid hormone treatment may be more prevalent than we realise.

Choi AR, Manning P. Choi AR, et al. N Z Med J. 2009 Feb 13;122(1289):93-4. N Z Med J. 2009. PMID: 19305457 No abstract available.

2

Endogenous subclinical hyperthyroidism: who, when and why to treat.

Biondi B. Biondi B. Expert Rev Endocrinol Metab. 2011 Nov;6(6):785-792. doi: 10.1586/eem.11.69. Expert Rev Endocrinol Metab. 2011. PMID: 30780873

3

Prospectively measured triiodothyronine levels are positively associated with breast cancer risk in postmenopausal women.

Tosovic A, Bondeson AG, Bondeson L, Ericsson UB, Malm J, Manjer J. Tosovic A, et al. Breast Cancer Res. 2010;12(3):R33. doi: 10.1186/bcr2587. Epub 2010 Jun 11. Breast Cancer Res. 2010. PMID: 20540734 Free PMC article.

4

Radioiodine treatment for benign thyroid disorders: results of a nationwide survey of UK endocrinologists.

Vaidya B, Williams GR, Abraham P, Pearce SH. Vaidya B, et al. Clin Endocrinol (Oxf). 2008 May;68(5):814-20. doi: 10.1111/j.1365-2265.2007.03097.x. Epub 2007 Oct 31. Clin Endocrinol (Oxf). 2008. PMID: 17973939

5

Serum thyroid stimulating hormone level for predicting utility of thyroid uptake and scan.

Buehler L, Movahed A, Zhou K, Lansang MC. Buehler L, et al. Endocr Res. 2021 Feb;46(1):10-13. doi: 10.1080/07435800.2020.1810064. Epub 2020 Sep 2. Endocr Res. 2021. PMID: 32875953

6

A clinical and therapeutic approach to thyrotoxicosis with thyroid-stimulating hormone suppression only.

Papi G, Pearce EN, Braverman LE, Betterle C, Roti E. Papi G, et al. Am J Med. 2005 Apr;118(4):349-61. doi: 10.1016/j.amjmed.2005.01.004. Am J Med. 2005. PMID: 15808130 Review.

7

Subclinical thyroid disorders: significance and clinical impact.

Razvi S, Weaver JU, Pearce SH. Razvi S, et al. J Clin Pathol. 2010 May;63(5):379-86. doi: 10.1136/jcp.2008.057414. J Clin Pathol. 2010. PMID: 20418229 Review.

8

The effect of radioiodine treatment on the diseased thyroid gland.

Riley AS, McKenzie GAG, Green V, Schettino G, England RJA, Greenman J. Riley AS, et al. Int J Radiat Biol. 2019 Dec;95(12):1718-1727. doi: 10.1080/09553002.2019.1665206. Epub 2019 Sep 16. Int J Radiat Biol. 2019. PMID: 31486712 Review.

9

Physician Choice of Hypothyroidism Therapy: Influence of Patient Characteristics.

Jonklaas J, Tefera E, Shara N. Jonklaas J, et al. Thyroid. 2018 Nov;28(11):1416-1424. doi: 10.1089/thy.2018.0325. Thyroid. 2018. PMID: 30289349 Free PMC article.

10

Approach to the patient with subclinical hyperthyroidism.

Cooper DS. Cooper DS. J Clin Endocrinol Metab. 2007 Jan;92(1):3-9. doi: 10.1210/jc.2006-2472. J Clin Endocrinol Metab. 2007. PMID: 17209221

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results